207 related articles for article (PubMed ID: 35775280)
1. Vaginal microbiota associated with oncogenic HPV in a cohort of HPV-vaccinated women living with HIV.
McClymont E; Albert AY; Wang C; Dos Santos SJ; Coutlée F; Lee M; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Yudin MH; Harris M; Wobeser W; Hill JE; Money DM;
Int J STD AIDS; 2022 Aug; 33(9):847-855. PubMed ID: 35775280
[TBL] [Abstract][Full Text] [Related]
2. HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV.
McClymont E; Tan DH; Bondy S; Albert A; Coutlée F; Lee M; Walmsley S; Ogilvie G; Money D
Int J STD AIDS; 2023 May; 34(6):402-407. PubMed ID: 36702811
[TBL] [Abstract][Full Text] [Related]
3. Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination.
McClymont E; Lee M; Raboud J; Coutlée F; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Harris M; Cohen J; Yudin MH; Wobeser W; Money D
Int J Gynaecol Obstet; 2020 Jul; 150(1):108-115. PubMed ID: 32342504
[TBL] [Abstract][Full Text] [Related]
4. Brief Report: Persistence of Non-Vaccine Oncogenic HPV Genotypes in Quadrivalent HPV-Vaccinated Women Living With HIV.
McClymont E; Coutlée F; Lee M; Albert A; Raboud J; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Yudin MH; Harris M; Wobeser W; Bitnun A; Samson L; Money D;
J Acquir Immune Defic Syndr; 2020 Mar; 83(3):230-234. PubMed ID: 31917750
[TBL] [Abstract][Full Text] [Related]
5. Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria.
Musa J; Maiga M; Green SJ; Magaji FA; Maryam AJ; Okolo M; Nyam CJ; Cosmas NT; Silas OA; Imade GE; Zheng Y; Joyce BT; Diakite B; Morhason-Bello I; Achenbach CJ; Sagay AS; Ujah IAO; Murphy RL; Hou L; Mehta SD
BMC Cancer; 2023 Jul; 23(1):683. PubMed ID: 37474918
[TBL] [Abstract][Full Text] [Related]
6. The vaginal microbiota of women living with HIV on suppressive antiretroviral therapy and its relation to high-risk human papillomavirus infection.
Chávez-Torres M; Gómez-Palacio-Schjetnan M; Reyes-Terán G; Briceño O; Ávila-Ríos S; Romero-Mora KA; Pinto-Cardoso S
BMC Microbiol; 2023 Jan; 23(1):21. PubMed ID: 36658503
[TBL] [Abstract][Full Text] [Related]
7. Long-term human papillomavirus vaccination effectiveness and immunity in Rwandan women living with and without HIV: a study protocol.
Murenzi G; Shumbusho F; Hansen N; Munyaneza A; Gage JC; Muhoza B; Kanyabwisha F; Pierz A; Tuyisenge P; Anastos K; Castle PE
BMJ Open; 2022 Aug; 12(8):e061650. PubMed ID: 36008069
[TBL] [Abstract][Full Text] [Related]
8. Altered Vaginal Microbiota Composition Correlates With Human Papillomavirus and Mucosal Immune Responses in Women With Symptomatic Cervical Ectopy.
López-Filloy M; Cortez FJ; Gheit T; Cruz Y Cruz O; Cruz-Talonia F; Chávez-Torres M; Arteaga-Gómez C; Mancilla-Herrera I; Montesinos JJ; Cortés-Morales VA; Aguilar C; Tommasino M; Pinto-Cardoso S; Rocha-Zavaleta L
Front Cell Infect Microbiol; 2022; 12():884272. PubMed ID: 35656032
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus.
McClymont E; Lee M; Raboud J; Coutlée F; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Harris M; Cohen J; Yudin MH; Wobeser W; Money D;
Clin Infect Dis; 2019 Feb; 68(5):788-794. PubMed ID: 29985988
[TBL] [Abstract][Full Text] [Related]
11. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis.
Norenhag J; Du J; Olovsson M; Verstraelen H; Engstrand L; Brusselaers N
BJOG; 2020 Jan; 127(2):171-180. PubMed ID: 31237400
[TBL] [Abstract][Full Text] [Related]
12. Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection.
Wei ZT; Chen HL; Wang CF; Yang GL; Han SM; Zhang SL
Front Public Health; 2020; 8():587298. PubMed ID: 33490017
[TBL] [Abstract][Full Text] [Related]
13. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
14. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection.
Di Paola M; Sani C; Clemente AM; Iossa A; Perissi E; Castronovo G; Tanturli M; Rivero D; Cozzolino F; Cavalieri D; Carozzi F; De Filippo C; Torcia MG
Sci Rep; 2017 Aug; 7(1):10200. PubMed ID: 28860468
[TBL] [Abstract][Full Text] [Related]
16. Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women.
Hessol NA; Holly EA; Efird JT; Minkoff H; Weber KM; Darragh TM; Burk RD; Strickler HD; Greenblatt RM; Palefsky JM
AIDS; 2013 Jul; 27(11):1743-51. PubMed ID: 23803793
[TBL] [Abstract][Full Text] [Related]
17. Relationship between vaginal and oral microbiome in patients of human papillomavirus (HPV) infection and cervical cancer.
Zhang W; Yin Y; Jiang Y; Yang Y; Wang W; Wang X; Ge Y; Liu B; Yao L
J Transl Med; 2024 Apr; 22(1):396. PubMed ID: 38685022
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
19. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
[TBL] [Abstract][Full Text] [Related]
20. The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania.
Mayaud P; Gill DK; Weiss HA; Uledi E; Kopwe L; Todd J; ka-Gina G; Grosskurth H; Hayes RJ; Mabey DC; Lacey CJ
Sex Transm Infect; 2001 Aug; 77(4):248-54. PubMed ID: 11463923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
